Judy Cheng, PharmD, MPH, FCCP, BCPS, RPh
Professor and Chair, Department of Pharmacy Practice
School
School of Pharmacy
Department
Pharmacy Practice
Office Location
White 346
Boston
Office Phone Office Phone: 617.732.2868
About
Judy W.M. Cheng, Pharm.D., MPH, FCCP, BCPS (AQ in Cardiology), is Professor of Pharmacy Practice and Chair of Department of Pharmacy Practice at MCPHS. Professor Cheng’s area of clinical practice and research interest is cardiovascular pharmacotherapy. She maintains an active clinical pharmacy practice in this area at Brigham and Women’s Hospital in Boston. She has published over 140 peer-reviewed manuscripts and book chapters relating to cardiovascular pharmacy practice. In 2004, she received recognition for her work in the pharmacy profession by being named Fellow of the American College of Clinical Pharmacy.
Education
- University of Toronto, Bachelor of Science in Pharmacy (BS)
- Philadelphia College of Pharmacy and Health Sciences (PharmD)
- Mount Sinai School of Medicine (MPH)
- St. Michael's Hospital, Pharmacy Practice Residency
- Philadelphia College of Pharmacy and Health Sciences/Hospital of University of Pennsylvania (Fellowship in Cardiovascular Pharmacotherapy)
- Board of Pharmaceutical Specialties (Board Certified Pharmacotherapy Specialist, with Added Qualification in Cardiology)
Research Interests
- Cardiovascular Pharmacotherapy
- Heart Failure
- Pharmacy Education
Featured Affiliations
American Association of College of Pharmacy
American College of Clinical Pharmacy
American Society of Health System Pharmacists
Education
- University of Toronto, Bachelor of Science in Pharmacy (BS)
- Philadelphia College of Pharmacy and Health Sciences (PharmD)
- Mount Sinai School of Medicine (MPH)
- St. Michael's Hospital, Pharmacy Practice Residency
- Philadelphia College of Pharmacy and Health Sciences/Hospital of University of Pennsylvania (Fellowship in Cardiovascular Pharmacotherapy)
- Board of Pharmaceutical Specialties (Board Certified Pharmacotherapy Specialist, with Added Qualification in Cardiology)
Research Interests
- Cardiovascular Pharmacotherapy
- Heart Failure
- Pharmacy Education
Publications
- Cheng JW, Colucci V, Kalus JS, Spinler S. Focused updates: SGLT2 inhibitors in patients with heart failure and/or chronic kidney disease. Ann Pharmacother 2021;55(2):252-60.
- Buckley L, Cheng JW, Desai A. Cardiovascular pharmacology in the time of COVID-19: A focus on angiotensin-converting enzyme 2020;75:526-9.
- Kelly J, Cheng JW, Malloy R, Lupi K. Comparison of positive inotropic agents in the management of acute decompensated heart failure. Journal of Cardiovascular Pharmacology 2020;75:455-9.
- Cheng JWM, Colucci V, Kalus JS, Spinler SA. Reply: managing diabetes and preventing disease: have we found a safe and effective agent? Annals Pharmacother 2019 Jul 4:1060028019862262. doi: 10.1177/1060028019862262. [Epub ahead of print]
- Cheng JWM. Updates on direct oral anticoagulants in manangement of atrial fibrillation. European Journal of Arrhythmia & Electrophysiology. 2019;5(1):24-9.
- Cheng JW. Current perspectives on the role of the pharmacist in heart failure management. Integrated Pharmacy Research and Practice 2018;7:1-11.
- Cheng JW, Badreldin HA, Patel DK, Bhatt SH. Antidiabetic agents and cardiovascular outcomes in patients with heart diseases. Current Medical Research and Opinion Curr Med Res Opin.
- 2017 Jun;33(6):985-992.
- Buckley LF, Rybak E, Aldemerdash A, Cheng JW, Fanikos J. Direct oral anticoagulants in patients with atrial fibrillation and renal impairment, extremes in weight or advanced age. Clin Cardiol 2017;40(1):46-52.
- Cheng JWM. Chapter 9 Essential Hypertension. In: Zeind C, Carvalho M, editoris. Applied Therapeutics. 11th Ed. Wolters Kluwer (2017)
- Cheng JWM, Nappi J. Section Editor, Cardiac and Vascular Disorders. In Zeind C, Carvalho M, editors. Applied Therapeutics. 11th Ed. Wolters Kluwer (2017).
- Buckley LF, Swoane-Vazquez E, Cheng JW, Aldemerdash A, Cooper IM, Matta L, Medina DS, Mehra MR, Navarro-Velez K, Shea EL, Weintraub JR, Stevenson LW, Desai AS. Comparison of ambulatory, high dose, intravenous diuretic therapy to standard hospitalization and diuretic therapy for treatment of acute decompensated heart failure. Am J Cardiol 2016;118(9):1350- 1355.
- Cheng JW. Impact of selective platelet inhibition in reducing cardiovascular risk – role of vorapaxar. Vascular Health and Riak Management 2016; 12:263-8.
- Cheng JW, Colucci V, Howard PA, Nappi JM, Spinler SA. Vorapaxar in atherosclerotic disease management. Ann Pharmacother 2015;49(5):599-606.
Awards and Honors
- 2020 Phi Kappa Phi Faculty Inductee
- 2018 Preceptor of the Year Award-Brigham and Women’s Hospital 2017 Preceptor of the Year Award – MCPHS University
- 2016 Excellence in Scholarship in Integration Award – MCPHS University
- 2014 Partners in Excellence Award – Brigham and Women’s Hospital for collaborative establishment of an outpatient Heart Failure Infusion Center
- 2014 Excellence in Scholarship in Integration Award – MCPHS University
- 2013 Excellence in Scholarship in Teaching and Integration Award – MCPHS University 2013 American College of Clinical Pharmacy Volunteer Recognition
- 2012 Research Mentor Award-Summer Undergraduate Research Fellowship Program – Massachusetts College of Pharmacy and Health Sciences
- 2011 Short-Term Service Award – Massachusetts College of Pharmacy and Health Sciences
- 2011 MCPHS School of Pharmacy Boston – Teacher
- 2010 Research Mentor Award-Summer Undergraduate Research Fellowship Program – Massachusetts College of Pharmacy and Health Sciences
- 2010 Faculty Research/Scholarship Award (Scholarship in Integration) – Massachusetts College of Pharmacy and Health Sciences
- 2007 Young Alumnus Award – University of Science in Philadelphia 2007 Founders’ Award for service contribution – Long Island University 2004 Fellow, American College of Clinical Pharmacy
- 2004 Newton’s Award for Excellence in Teaching – Long Island University 2002 Patient Care Award – Mount Sinai Medical Center
More Affiliations
- American Heart Association
- American College of Cardiology